Jianhua Yu

39PUBLICATIONS
117CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Feb 04, 2026
Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia development.

Zhenlong Li, Rui Ma, Hejun Tang

|Jan 06, 2026
Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy.

Ruiheng Wang, Jianhua Yu, Michael A Caligiuri

|Aug 18, 2025
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy.

Sai Xiao, Songqi Duan, Yaqun Hong

|Feb 01, 2025
miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape.

Fang Chen, Dandan Zhao, Yongfang Xu

|Jan 24, 2025
NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity.

Rui Ma, Zhenlong Li, Hejun Tang

|May 23, 2024
Black raspberry-mediated metabolic changes in patients with familial adenomatous polyposis associated with rectal polyp regression.

Yi-Wen Huang, Hui-Zhi Chen, Ben Niu

Pageof 7

Frequent Collaborators

20 joint publications

Michael Caligiuri

6 joint publications

Shoubao Ma

6 joint publications

Li-Shu Wang

5 joint publications

Yi-Wen Huang